The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pegylated liposomal doxorubicin (PLD) as an active treatment option for desmoid tumor (DT) patients.
 
Angela Pang
No Relationships to Disclose
 
Daniela Venancio Gouveia Macedo
No Relationships to Disclose
 
Mariana Carbini
No Relationships to Disclose
 
Robert G. Maki
Stock and Other Ownership Interests - Gilead Sciences
Honoraria - Janssen
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; Lilly/ImClone; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Epizyme (Inst); Immune Design (Inst); Lilly (Inst); Novartis (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - Bayer/Onyx; Janssen Oncology; TRACON Pharma